Novanta Inc

Novanta Inc(NOVT)股票分析

$140.800

+4.266 (+3.03%)收盘时

Loading chart…
最高
141.279
开盘
135.220
成交量加权均价
138.09
成交量
392.80K
市值
—
最低
132.195
成交额
54.24M
企业价值/息税折旧摊销前利润(TTM)
22.84

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.

AI 分析 of Novanta Inc (NOVT)

卖出

Currently, Novanta Inc. (NOVT) is not a good buy. The stock is trading at $128.79, significantly below its analyst price target of $194, but recent performance shows a concerning RSI of 24.523, indicating oversold conditions. Additionally, insider selling has increased by 134.30% over the last month, which raises red flags about management's confidence in the company's near-term prospects. The stock has also seen a 5-day change of -8.84%, suggesting negative momentum. The main risk is the high P/E ratio of 82.54, indicating that the stock may be overvalued compared to its earnings potential.

分析师评级(1)

买入
1 买入
0 持有
0 卖出
当前: 140.80
最低
—
平均
—
最高
—

Baird

2026-08-07

目标价

$194

跑赢大盘

Baird

2026-05-13

目标价

$173

跑赢大盘

Baird

2026-03-30

目标价

$144

跑赢大盘

Baird

2026-02-25

目标价

$150

中性

Baird

2025-08-11

目标价

$133

中性

估值指标

Novanta Inc(NOVT)当前预期市盈率为 8.39,5 年平均预期市盈率为 39.31。

预期市盈率

严重低估
5 年均值 P/E
39.31
当前P/E
8.39
高估
54.37
低估
24.26

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
26.86
当前EV/EBITDA
22.84
高估
31.23
低估
22.48

预期市销率

低估
5 年均值 P/S
5.43
当前P/S
4.03
高估
6.39
低估
4.47

Alphio AI 对 NOVT 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%NOVT

$155.23

情景价格

基

基准

基准 · 50%NOVT

$145.52

情景价格

悲

悲观

悲观 · 25%NOVT

$116.12

情景价格

持有 NOVT 的大户

B

Baron Capital Group, Inc.

+ 持有NOVT

+12.16%

3个月收益率

C

CastleArk Management LLC

+ 持有NOVT

+4.66%

3个月收益率

C

Champlain Investment Partners, LLC

+ 持有NOVT

+4.24%

3个月收益率

S

Southpoint Capital Advisors LP

+ 持有NOVT

+3.51%

3个月收益率

O

Osterweis Capital Management, Inc.

+ 持有NOVT

+3.08%

3个月收益率

F

Fenimore Asset Management, Inc.

+ 持有NOVT

-0.58%

3个月收益率

事件时间线

2026-08-05 (ET)

17:00:00

Sees FY26 Revenue of $1.13B-$1.14B

17:00:00

Novanta Reports Q2 Revenue of $265.8 Million

17:00:00

Sees Q3 Revenue of $300M-$304M

2026-07-27 (ET)

08:30:00

Novanta Completes Acquisition of Riverpoint Medical

2026-06-29 (ET)

17:30:00

Selling Stockholders Plan to Sell 2.14M Common Shares

资讯

NOVT 常见问题 —— 由 Alphio AI 解答

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others. It operates in the Technology sector (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SU industry).

Currently, Novanta Inc. (NOVT) is not a good buy. The stock is trading at $128.79, significantly below its analyst price target of $194, but recent performance shows a concerning RSI of 24.523, indicating oversold conditions. Additionally, insider selling has increased by 134.30% over the last month, which raises red flags about management's confidence in the company's near-term prospects. The stock has also seen a 5-day change of -8.84%, suggesting negative momentum. The main risk is the high P/E ratio of 82.54, indicating that the stock may be overvalued compared to its earnings potential.

1 analysts cover NOVT: 1 rate it Buy, 0 Hold and 0 Sell.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易